EAR
Market cap | $0.00 |
---|---|
Enterprise Value | $-38,369,000.00 |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-7.57 |
Beta | 0.0 |
Outstanding Shares | 20,772,485 |
Avg 30 Day Volume | 0 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 0.0 |
---|---|
PEG | -0.0 |
Price to Sales | 2.57 |
Price to Book Ratio | 1.29 |
Enterprise Value to Revenue | -0.93 |
Enterprise Value to EBIT | 0.43 |
Enterprise Value to Net Income | 0 |
Total Debt to Enterprise | -0.2 |
Debt to Equity | 0.17 |
No data
No data
Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss. The Company's innovative product and go-to-market approach address the major challenges of traditional hearing aid adoption, includ...